Two new papers by a team of researchers demonstrate that evaluating microRNAs in blood can be used not only to diagnose mild cognitive impairment (MCI) but also, critically, to predict the conversion ...
News Medical on MSN2d
Blood microRNAs can predict conversion from mild cognitive impairment to dementia due to Alzheimer’s diseaseAlzheimer's disease is a neurodegenerative disease characterized by ... previous research showing that disordered energy and ...
This year's World Alzheimer's Day campaign aims to address the stigma and discrimination while highlighting global efforts to ...
Alzheimer patient care can present a variety of barriers. A patient-centered approach and transdisciplinary care team model ...
Phase 2 trial is designed to evaluate the safety, efficacy, tolerability, and pharmacodynamics of SPG302 in adults with a ...
Technology Networks interviewed Professor Henrik Zetterberg on World Alzheimer’s Day 2024 to learn more about his work and ...
After more than a century since Alois Alzheimer's description of an “unusual illness of the cerebral cortex”, the development ...
Once McEwan, now at the UK Dementia Research Institute at the University of ... “What really pays is the molecular ...
The failure to diagnose Alzheimer's disease, the most common form of dementia in the elderly, at an early stage of molecular ...
The liver function in post-cardiac arrest brain injury is not known and was investigated in a pig model of global cerebral ...
With an FDA action date of Sept. 26, Bristol Myers Squibb’s KarXT could soon be the first new type of schizophrenia drug in ...
Study explores the potential to repurpose neuroactive drugs, originally approved for neurological disorders, for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback